Technical Considerations in Stereotactic Ablative Radiotherapy for Localized Neuroendocrine Cancer of the Lung: Case Report and Review of the Literature

Abstract

Abstract Stereotactic ablative radiotherapy as a treatment option for stage I neuroendocrine cancer of the lung is not yet well understood. While analogs can be made to non-small cell lung cancer, high-grade neuroendocrine tumors are very radioresponsive and, therefore, present unique challenges around tumor localization. We present a case of stage I high-grade neuroendocrine lung cancer treated with SABR and the technical considerations surrounding changes in tumor location and morphology.